Outlook Quality of Life Intervention

计划入组 36 人 · 首次发布于 2008 年 11 月 2 日

Youth Outlook on Life Opportunities Study

计划入组 1,000 人 · 首次发布于 2021 年 8 月 30 日

Outlook Quality of Life Intervention Study

计划入组 221 人 · 首次发布于 2010 年 1 月 7 日

Adalimumab biosimilar(Outlook Therapeutics, Inc.)

NaV1.7 inhibitor (injectable depot, surgical pain)

Iodine povacrylex(Duraprep)

Outlook Therapeutics

United States

OUTLOOK THERAPEUTICS LIMITED

Ireland

ACTIV SURGICAL

India

Outlook Surgical Receives FDA 510(k) Clearance for Revolutionary Hybrid Endoscope System

Outlook Therapeutics Announces Executive Leadership Transition

Vicarious Surgical On Track for First Surgical Robot Trials in Mid-to-Late 2025